Breaking News Instant updates and real-time market news.

CAH

Cardinal Health

$73.31

0.79 (1.09%)

, MDT

Medtronic

$81.02

0.7 (0.87%)

08:53
04/21/17
04/21
08:53
04/21/17
08:53

Cardinal Health price target lowered to $72 from $81 at Leerink

Leerink analyst David Larsen lowered his price target for Cardinal Health (CAH) to $72 from $81 to account for the updated guidance provided by management, as well as the acquisition of Medtronic's (MDT) Patient Recovery business. The analyst reiterates a Market Perform rating on Cardinal Health's shares.

CAH

Cardinal Health

$73.31

0.79 (1.09%)

MDT

Medtronic

$81.02

0.7 (0.87%)

  • 22

    Apr

  • 01

    May

  • 06

    Jun

CAH Cardinal Health
$73.31

0.79 (1.09%)

04/19/17
WBLR
04/19/17
DOWNGRADE
WBLR
Market Perform
William Blair downgrades Cardinal Health on 'alarming' pharma outlook
William Blair analyst John Kreger downgraded Cardinal Health (CAH) to Market Perform from Outperform saying that while the Medtronic (MDT) asset purchase is a positive step, yesterday's guidance update suggests that pressures on the pharma distribution business are continuing. The analyst views the outlook as "alarming" and now sees a lower earnings outlook for FY18 and beyond.
04/19/17
WBLR
04/19/17
DOWNGRADE
WBLR
Market Perform
Cardinal Health downgraded to Market Perform from Outperform at William Blair
William Blair analyst John Kreger downgraded Cardinal Health to Market Perform.
04/18/17
LEER
04/18/17
NO CHANGE
LEER
Market Perform
Cardinal Health struggles may be benefitting AmerisourceBergen, says Leerink
Leerink analyst David Larsen noted that Cardinal Health (CAH) pointed to generic pricing and sell-side pressure and incremental investments as primary reasons for its FY18 and FY19 adjusted EPS forecasts missing expectations, but he believes there may be other challenges the business is facing too. Cardinal's loss of Prime Therapeutics and Walgreens' (WBA) recent wins from CVS Health (CVS) are other factors that may have hurt Cardinal, said Larsen, who added that both of those will benefit AmerisourceBergen (ABC). The analyst, who also said he is incrementally more cautious on McKesson (MCK) and Owens & Minor (OMI) after Cardinal's call, has an Outperform rating on AmerisourceBergen and Market Perform ratings on Cardinal Health, McKesson and O&M.
04/06/17
EVER
04/06/17
UPGRADE
Target $91.5
EVER
Outperform
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Ross Muken upgraded Cardinal Health to Outperform with a $91.50 price target given his improving view of end markets. The analyst said the past year has been difficult for pharma distributors and believes the period of negative earnings revisions is likely over. Year-over-year generic deflation has moderated and Cardinal has lessened its dependence on branded inflation by moving to fee for service for over 85% of its portfolio, while pricing for independent pharmacy contracts appears to have stabilized, Muken wrote in an report. Additionally, the analyst said Cardinal has a superior position in procurement through Red Oak and continues to build out its Medical business as well as having highly visible capital deployment.
MDT Medtronic
$81.02

0.7 (0.87%)

04/13/17
COWN
04/13/17
NO CHANGE
Target $90
COWN
Outperform
Cowen sees Apple threat to Dexcom as 'only hype/hope' at this point
The slide in Dexcom (DXCM) shares this morning is "seemingly due" to a report saying Apple (AAPL) is working on a non-invasive glucose sensor, said Cowen analyst Doug Schenkel, but he cautions that other companies have been trying to do the same for decades and all have failed. While you can " never say never," Schenkel views it as "extremely unlikely" that Apple has succeeded and he will not be worried about this threat to Dexcom until he sees data, he tells investors. Beyond today's dip, a move in Dexcom shares from their recent highs is due to heightened investor focus on nearer-term competitive products coming later this year from Medtronic (MDT) and Abbott (ABT), noted Schenkel, who keeps an Outperform rating and $90 price target on Dexcom.
04/07/17
SBSH
04/07/17
NO CHANGE
Target $93
SBSH
Buy
Citi makes Medtronic top sector pick after endocrinologist survey
Citi analyst Amit Hazan says his firm's semi-annual survey of 40 U.S. endocrinologists has come back "significantly more positive" for Medtronic (MDT). The analyst makes the stock his top pick in Medical Supplies for the rest of 2017, replacing Boston Scientific (BSX) and Intuitive Surgical (ISRG). The survey shows "significant" new shares gains for Medtronic in pumps and the CGM segment, Hazan tells investors in a research note. The analyst keeps a Buy rating on Medtronic with a $93 price target.
04/06/17
WELS
04/06/17
NO CHANGE
WELS
Medtronic data 'mostly encouraging,' says Wells Fargo
Wells Fargo says that the results of a trial of Medtronic's HVAD left ventricular assist device for destination therapy was "mostly positive." Even though the device missed the primary endpoint of neurological events, it showed superiority on the more traditional endpoint of survival at 12 months without debilitating illness , while the stroke rates of patients that had it were similar to those of Abbott's (ABT) HeartMate and hemorrhagic stroke rates fell 50% versus a previous trial. Wells keeps an Outperform rating on Medtronic.
03/14/17
RBCM
03/14/17
NO CHANGE
RBCM
Medtronic pump delay a negative for United Therapeutics, says RBC Capital
After the FDA posted on its website that Medtronic (MDT) is recalling the SynchroMed Implantable Infusion Pumps because of a software problem, RBC Capital said this new recall may impact the timeline for United Therapeutics (UTHR) implantable pump. In March of last year, United Therapeutics said that Medtronic and the company were assessing a U.S. Food and Drug Administration response letter to Medtronic's premarket approval application, PMA, for the Remodulin Implantable System and measures to address the agency's concerns.

TODAY'S FREE FLY STORIES

NXTM

NxStage Medical

$23.46

0.13 (0.56%)

21:43
06/26/17
06/26
21:43
06/26/17
21:43
Initiation
NxStage Medical initiated  »

NxStage Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

21:40
06/26/17
06/26
21:40
06/26/17
21:40
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

BL

BlackLine

$37.80

-0.26 (-0.68%)

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
BlackLine initiated at SunTrust »

BlackLine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTI

Ultimate Software

$221.91

-0.25 (-0.11%)

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
Ultimate Software initiated at SunTrust »

Ultimate Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

CRM

Salesforce

$88.11

-0.51 (-0.58%)

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
Salesforce initiated at SunTrust »

Salesforce initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVBG

Everbridge

$24.66

-0.3 (-1.20%)

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
Everbridge initiated at SunTrust »

Everbridge initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNG

RingCentral

$37.65

-1 (-2.59%)

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
RingCentral initiated at SunTrust »

RingCentral initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WK

Workiva

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
Workiva initiated at SunTrust »

Workiva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUBS

HubSpot

$68.20

-0.7 (-1.02%)

20:56
06/26/17
06/26
20:56
06/26/17
20:56
Initiation
HubSpot initiated at SunTrust »

HubSpot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

HUBS

HubSpot

$68.20

-0.7 (-1.02%)

20:55
06/26/17
06/26
20:55
06/26/17
20:55
Initiation
HubSpot initiated at SunTrust »

HubSpot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

QTWO

Q2 Holdings

20:55
06/26/17
06/26
20:55
06/26/17
20:55
Initiation
Q2 Holdings initiated at SunTrust »

Q2 Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

INST

Instructure

$29.55

0.4 (1.37%)

20:55
06/26/17
06/26
20:55
06/26/17
20:55
Initiation
Instructure initiated at SunTrust »

Instructure initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

MANH

Manhattan Associates

20:55
06/26/17
06/26
20:55
06/26/17
20:55
Initiation
Manhattan Associates initiated at SunTrust »

Manhattan Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCTY

Paylocity

$47.39

-1.65 (-3.36%)

20:55
06/26/17
06/26
20:55
06/26/17
20:55
Initiation
Paylocity initiated at SunTrust »

Paylocity initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 11

    Jul

SHOP

Shopify

$92.04

-2.44 (-2.58%)

20:55
06/26/17
06/26
20:55
06/26/17
20:55
Initiation
Shopify initiated at SunTrust »

Shopify initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$152.30

0.68 (0.45%)

20:10
06/26/17
06/26
20:10
06/26/17
20:10
Downgrade
LabCorp rating change at KeyBanc »

LabCorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATXI

Avenue Therapeutics

20:06
06/26/17
06/26
20:06
06/26/17
20:06
Syndicate
Avenue Therapeutics 5.5M share IPO priced at $6.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

NXPI

NXP Semiconductors

$109.73

-0.25 (-0.23%)

20:05
06/26/17
06/26
20:05
06/26/17
20:05
Hot Stocks
NXP Semi collaborates with Shanghai Unicom, roam2free on eSIM solution »

NXP Semiconductors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

PDCE

PDC Energy

$42.88

-1.84 (-4.11%)

19:21
06/26/17
06/26
19:21
06/26/17
19:21
Hot Stocks
PDC Energy CEO 'disappointed' with Clean Air Act complaint »

Today, the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MRIN

Marin Software

$1.18

0.025 (2.17%)

19:17
06/26/17
06/26
19:17
06/26/17
19:17
Hot Stocks
Marin Software names Brad Kinnish CFO »

Marin Software announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$34.52

0.32 (0.94%)

19:15
06/26/17
06/26
19:15
06/26/17
19:15
Earnings
General Motors: Previous FY17 EPS view unchanged »

General Motors said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 25

    Jul

GM

General Motors

$34.52

0.32 (0.94%)

19:04
06/26/17
06/26
19:04
06/26/17
19:04
Hot Stocks
General Motors lowers view of 2017 U.S. car industry »

On a conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 25

    Jul

BLKB

Blackbaud

$89.25

-0.25 (-0.28%)

, CST

CST Brands

$48.54

0.18 (0.37%)

18:56
06/26/17
06/26
18:56
06/26/17
18:56
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P SmallCap 600…

BLKB

Blackbaud

$89.25

-0.25 (-0.28%)

CST

CST Brands

$48.54

0.18 (0.37%)

NSA

National Storage

$22.63

0.22 (0.98%)

ANCUF

Alimentation Couche-Tard

$48.08

1.9887 (4.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$34.52

0.32 (0.94%)

18:52
06/26/17
06/26
18:52
06/26/17
18:52
Hot Stocks
General Motors raises expected Opel sale charge to $5.5B »

On a conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 25

    Jul

WMT

Wal-Mart

$75.50

0.66 (0.88%)

18:43
06/26/17
06/26
18:43
06/26/17
18:43
Periodicals
Wal-Mart sued for wrongful death of Illinois Uber driver, Reuters reports »

The family of an Illinois…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.